BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 15655334)

  • 1. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast responses to nucleotides increase during differentiation.
    Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
    Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P2X7 ATP receptor modulates renal cyst development in vitro.
    Hillman KA; Woolf AS; Johnson TM; Wade A; Unwin RJ; Winyard PJ
    Biochem Biophys Res Commun; 2004 Sep; 322(2):434-9. PubMed ID: 15325248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic activation of Akt signalling pathway in Han:SPRD rats with polycystic kidney disease.
    Wahl PR; Le Hir M; Vogetseder A; Arcaro A; Starke A; Waeckerle-Men Y; Serra AL; Wuthrich RP
    Nephrology (Carlton); 2007 Aug; 12(4):357-63. PubMed ID: 17635750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of P2 nucleotide receptor subtypes during development of the lateral ventricular choroid plexus of the rat.
    Johansson PA; Burnstock G; Dziegielewska KM; Guida E; McIntyre P; Saunders NR
    Eur J Neurosci; 2007 Jun; 25(11):3319-31. PubMed ID: 17553000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.
    Fischer W; Appelt K; Grohmann M; Franke H; Nörenberg W; Illes P
    Neuroscience; 2009 Jun; 160(4):767-83. PubMed ID: 19289154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
    Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
    Pey R; Bach J; Schieren G; Gretz N; Hafner M
    In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
    Cowley BD; Ricardo SD; Nagao S; Diamond JR
    Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.
    Berthier CC; Wahl PR; Le Hir M; Marti HP; Wagner U; Rehrauer H; Wüthrich RP; Serra AL
    Nephrol Dial Transplant; 2008 Mar; 23(3):880-9. PubMed ID: 18042615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the pro-apoptotic ATP-sensitive P2X7 receptor in experimental and human glomerulonephritis.
    Turner CM; Tam FW; Lai PC; Tarzi RM; Burnstock G; Pusey CD; Cook HT; Unwin RJ
    Nephrol Dial Transplant; 2007 Feb; 22(2):386-95. PubMed ID: 17040997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of epithelial transport via luminal P2 receptors.
    Leipziger J
    Am J Physiol Renal Physiol; 2003 Mar; 284(3):F419-32. PubMed ID: 12556361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys.
    Schwiebert EM; Wallace DP; Braunstein GM; King SR; Peti-Peterdi J; Hanaoka K; Guggino WB; Guay-Woodford LM; Bell PD; Sullivan LP; Grantham JJ; Taylor AL
    Am J Physiol Renal Physiol; 2002 Apr; 282(4):F763-75. PubMed ID: 11880338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing.
    Coutinho-Silva R; Parsons M; Robson T; Burnstock G
    Cell Tissue Res; 2001 Dec; 306(3):373-83. PubMed ID: 11735037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
    Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
    BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.
    Nagao S; Yamaguchi T; Kusaka M; Maser RL; Takahashi H; Cowley BD; Grantham JJ
    Kidney Int; 2003 Feb; 63(2):427-37. PubMed ID: 12631108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
    Tomé AR; Castro E; Santos RM; Rosário LM
    BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
    Tao Y; Kim J; Schrier RW; Edelstein CL
    J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.